Do you know how OncoSil works?
Unlock the science behind our innovative treatment and how it’s changing the landscape of pancreatic cancer care. Click here to learn more: https://t.co/1HujpZuKwI
Join us in advancing cancer care with OncoSil!
#OncoSil#CancerCare #InnovationInHealthcare #PancreaticCancerAwareness
We’re thrilled to announce the successful completion of training at Bilkent City Hospital. The dedicated team is now fully prepared and almost ready to treat their first patient with OncoSil therapy. A significant step in advancing cancer care and transforming lives in Turkey!
Amplia Therapeutics (ASX: $ATX) has suspended trading of its ATXOA options due to the absence of deferred settlement trading, as per ASX Listing Rule 17.3.
4/4
OncoSil Medical plans further market expansion with new distribution agreements in Europe and beyond, continuing their mission to redefine pancreatic cancer care.
1/4
Recent updates from OncoSil Medical $OSL highlight a 78% increase in the use of their pancreatic cancer treatment device in Q4 FY24, showing substantial growth 📈
3/4
Approval by major health insurer Clalit General Health Services is a key step for OncoSil Medical, enhancing the accessibility of their treatments in the Middle East.